The Utah Opioid Task Force and the Utah Finesse Task Force alerted community organizations, healthcare providers, first responders, and the public that medetomidine was detected in Utah's illicit drug supply.
Medetomidine is a potent synthetic veterinary sedative and painkiller that is not approved for human use. It has been increasingly used as a dangerous cutting agent within the illicit drug supply, frequently mixed with fentanyl.
The detection of this substance was identified through ongoing drug surveillance. According to a news release from the task forces, this discovery allows public health, public safety, and overdose prevention partners to provide timely guidance. The task forces stated that partners will continue monitoring the supply and sharing updates as they become available.
Medetomidine has been found increasingly in street drugs across the United States. After being first detected in 2022, it was linked to spikes in overdoses in cities such as Chicago, Pittsburgh, and Philadelphia by 2024. While it is now reported nationwide, the highest rates have been seen in the Midwest and Northeast.
This substance is substantially more potent than xylazine, another veterinary sedative. Although medetomidine is not an opioid and cannot be reversed by naloxone, the news release noted that naloxone remains essential during overdose responses because the substance is often mixed with opioids like fentanyl, heroin, or morphine.
The Utah Opioid Task Force and Utah Fentanyl Task Force stated that as the illicit drug supply evolves, new substances emerge alongside existing opioids. They emphasized the importance of recognizing an overdose, calling 911, carrying naloxone, and educating those at increased risk.
In the event of a suspected overdose, officials advised calling 911 immediately and administering naloxone to reverse any present opioids. Guidance includes focusing on breathing rather than wakefulness, providing rescue breaths if necessary, using the recovery position, and monitoring the individual until EMS arrives.
